403 results on '"Smits, Mark M."'
Search Results
2. Alpha-cyclodextrin increases glucagon-like peptide-1 secretion in multiple models and improves metabolic status in mice
3. Midostaurin as the Most Likely Cause of Bilateral Adrenal Masses in a Patient with Acute Myeloid Leukemia
4. Association between hypoglycaemic glucose variability and autonomic function in type1 diabetes with impaired hypoglycaemia awareness
5. Mechanisms underlying the blood pressure lowering effects of dapagliflozin, exenatide, and their combination in people with type 2 diabetes: a secondary analysis of a randomized trial
6. Whole-body insulin clearance in people with type 2 diabetes and normal kidney function: Relationship with glomerular filtration rate, renal plasma flow, and insulin sensitivity
7. Kidney hemodynamic profile and systemic vascular function in adults with type 2 diabetes: Analysis of three clinical trials
8. Liraglutide and sitagliptin have no effect on intestinal microbiota composition: A 12-week randomized placebo-controlled trial in adults with type 2 diabetes
9. In Vivo Inhibition of Dipeptidyl Peptidase 4 Allows Measurement of GLP-1 Secretion in Mice
10. Indole-3-carboxyaldehyde does not reverse the intestinal effects of fiber-free diet in mice
11. In Vivo Inhibition of Dipeptidyl Peptidase 4 Allows Measurement of GLP-1 Secretion in Mice.
12. The effect of liraglutide and sitagliptin on oxidative stress in persons with type 2 diabetes
13. GLP-1 receptor agonists do not affect sodium intake: Exploratory analyses from two randomized clinical trials
14. Renal sinus fat and renal hemodynamics: a cross-sectional analysis
15. SAT037 Glucagon-like Peptide-1 Receptor Knockout Mice Do Not Compensate For The Lack Of Incretin Action By Increasing Glucose-dependent Insulinotropic Polypeptide Secretion
16. Ectomycorrhizal Weathering of the Soil Minerals Muscovite and Hornblende
17. The Role of Fungi in Weathering
18. Tree Species Effects on Calcium Cycling: The Role of Calcium Uptake in Deep Soils
19. Endogenous glucagon‐like peptide (GLP)‐1 as alternative for GLP‐1 receptor agonists: Could this work and how?
20. Effects of dapagliflozin and gliclazide on the cardiorenal axis in people with type 2 diabetes
21. High Prevalence of Intraductal Papillary Mucinous Neoplasms in Type 2 Diabetes Mellitus Patients
22. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390
23. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial
24. Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390
25. Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390
26. Mechanisms underlying the blood pressure-lowering effects of empagliflozin, losartan and their combination in people with type 2 diabetes:A secondary analysis of a randomized crossover trial
27. Endogenous glucagon-like peptide (GLP)-1 as alternative for GLP-1 receptor agonists:Could this work and how?
28. Lixisenatide Versus Insulin Glulisine on Fasting and Postbreakfast Systemic Hemodynamics in Type 2 Diabetes Mellitus Patients
29. Pleiotropic effects of type 2 diabetes management strategies on renal risk factors
30. Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial
31. Soil fungi appear to have a retarding rather than a stimulating role on soil apatite weathering
32. Mechanisms underlying the blood pressure‐lowering effects of empagliflozin, losartan and their combination in people with type 2 diabetes: A secondary analysis of a randomized crossover trial
33. Postprandial renal haemodynamic effect of lixisenatide vs once‐daily insulin‐glulisine in patients with type 2 diabetes on insulin‐glargine: An 8‐week, randomised, open‐label trial
34. Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial
35. Adipocytokines as features of the metabolic syndrome determined using confirmatory factor analysis
36. High resolution characterization of ectomycorrhizal fungal-mineral interactions in axenic microcosm experiments
37. Postprandial renal hemodynamic effects of DPP-4 inhibitor linagliptin versus sulfonylurea glimepiride in adults with type 2 diabetes (RENALIS):a pre-defined sub-study of a randomized, double-blind trial
38. Postprandial renal haemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptin versus the sulphonylurea glimepiride in adults with type 2 diabetes (RENALIS):A predefined substudy of a randomized, double-blind trial
39. Whole-body insulin clearance in people with type 2 diabetes and normal kidney function: Relationship with glomerular filtration rate, renal plasma flow, and insulin sensitivity
40. Kidney hemodynamic profile and systemic vascular function in adults with type 2 diabetes: Analysis of three clinical trials
41. Postprandial renal haemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptin versus the sulphonylurea glimepiride in adults with type 2 diabetes (RENALIS): a pre-defined sub-study of a randomized, double-blind trial
42. Pancreatic Steatosis Is Not Associated With Exocrine Pancreatic Function in Overweight Type 2 Diabetes Patients
43. GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes
44. Corrigendum: Safety of Semaglutide (Front. Endocrinol., (2021), 12, (645563), 10.3389/fendo.2021.645563)
45. Rock-eating mycorrhizas: their role in plant nutrition and biogeochemical cycles
46. In situ atomic force microscopy measurements of biotite basal plane reactivity in the presence of oxalic acid
47. GLP-1 based therapies: clinical implications for gastroenterologists
48. Exenatide acutely increases heart rate in parallel with augmented sympathetic nervous system activation in healthy overweight males
49. Mechanisms underlying the blood pressure‐lowering effects of empagliflozin, losartan and their combination in people with type 2 diabetes: A secondary analysis of a randomized crossover trial.
50. Postprandial renal haemodynamic effects of the dipeptidyl peptidase‐4 inhibitor linagliptin versus the sulphonylurea glimepiride in adults with type 2 diabetes (RENALIS): A predefined substudy of a randomized, double‐blind trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.